Literature DB >> 3896296

Cyclosporine and graft failure following bone marrow transplantation for severe aplastic anaemia.

J Hows, S Palmer, E C Gordon-Smith.   

Abstract

Thirty-nine patients with severe aplastic anaemia were transplanted from HLA identical sibling donors. Irradiation was not used in the pre-transplant immunosuppressive protocol and cyclosporine was used as the post graft immunosuppressive agent. The incidence of primary graft failure (no take) was low occurring in 3/38 evaluable patients. Late graft failure 4-7.5 months post BMT occurred in five patients and was associated with withdrawal of cyclosporine therapy. Mixed lymphocyte chimaerism was demonstrated in 3/5 cases at the time of late graft failure and subsequent marrow recovery was autologous in four patients. Mortality from graft failure was low with 2/38 evaluable patients (5%) dying from this complication.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896296     DOI: 10.1111/j.1365-2141.1985.tb07463.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

Authors:  Richard E Champlin; Waleska S Perez; Jakob R Passweg; John P Klein; Bruce M Camitta; Eliane Gluckman; Christopher N Bredeson; Mary Eapen; Mary M Horowitz
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

2.  Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin.

Authors:  N Frickhofen; W Heit; A Raghavachar; F Porzsolt; H Heimpel
Journal:  Klin Wochenschr       Date:  1986-11-17

3.  Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor.

Authors:  P T Vo; J Pantin; C Ramos; L Cook; E Cho; R Kurlander; H Khuu; J Barrett; S Leitman; R W Childs
Journal:  J Hematol Oncol       Date:  2015-06-26       Impact factor: 17.388

4.  [Bone marrow transplantation in acute leukemia, chronic myeloid leukemia, severe aplastic anemia and stage IV neuroblastoma. Effect of antiviral prevention with anti-CMV-hyperimmunoglobulin and acyclovir].

Authors:  P Ostendorf; G Ehninger; R Dopfer; H Schmidt; M Haen; H Link; K Schüch; C A Müller; P Wernet; T Klingebiel
Journal:  Klin Wochenschr       Date:  1986-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.